Global Insulin Market Research Report 2019: Comprehensive Industry Analysis and Forecast Through 2015-2025HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global Insulin Market Research Report 2019: Comprehensive Industry Analysis and Forecast Through 2015-2025GlobeNewswireJanuary 2, 2020ReblogShareTweetShareDublin, Jan. 02, 2020 (GLOBE NEWSWIRE) -- The "Insulin Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018-2025" report has been added to ResearchAndMarkets.com's offering.The global demand for insulin market was valued at approximately USD 30.3 billion in 2018 and is expected to generate revenue of around USD 59.3 billion by end of 2025, growing at a CAGR of around 9.5% between 2019 and 2025.Report ScopeThis report covers forecast and analysis for the insulin market on a global and regional level. The study provides historic data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion).The study includes drivers and restraints for the insulin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities and various trends in the insulin market on a global level.Global demand for insulin market is anticipated to be driven by increase in awareness about the benefits of insulin for diabetes patients in developing and underdeveloped countries. The growing incidences of diabetes in population, rapid development in insulin delivery systems, drug and analog development by major companies, and rise in geriatric as well as obese population are some of the factors which are fueling the growth of the insulin market.Based on product type market is segmented into intermediate acting insulin, short acting insulin, rapid acting insulin, and long acting insulin. Short acting drugs generally include Novolin R and Humulin R. Insulin Lispro, Insulin Aspart, and Insulin Glulisine are some of the examples of rapid acting insulin. Long acting insulin includes insulin detemir, insulin degludec, and insulin glargine. NPH (Humulin N, Humulin N) are included in intermediate acting insulin.On the basis of source, the market is segmented into human recombinant insulin and insulin analogs. Human recombinant insulin is anticipated to show higher growth in the forecast period owing to its benefits and rapid actions as compared to insulin analogs. Also the growing awareness about the human recombinant insulin in developing countries is driving the growth of the segment.Based on administration, market is segmented into pumps and injections. Insulin is a drug which cannot be taken through oral route as the enzymes present in stomach will break down the insulin which prevents the action of insulin. Therefore pumps and injections are preferred to administer insulin in patient.On the basis of application, insulin market is fragmented into insulin for type II diabetes and insulin for type I diabetes. Insulin for type I diabetes dominated the application segment of insulin market owing to the high prevalence rate of type I diabetes. Also, a type I diabetes patient has to take insulin therapy for his whole lifetime; this also fuels the growth of the segment.North America dominated global insulin market and accounted for the highest market share in 2018. North America region is projected to lead the market over the forecast period owing to the presence of major consumer base in the U.S., growing cases of diabetes, rapid development in the ways to administer insulin, and presence of major players. Asia Pacific is expected to show a higher growth rate as compared to other regions. The rapid prevalence of diabetes in the population, presence of large geriatric population, growing awareness about the benefits of insulin, and technological advancement are some of the factors which are driving the market for insulin in Asia Pacific.Some of the key players in insulin market include Sanofi, Takeda Pharmaceuticals, Novo Nordisk, Bristol-Myers Squibb, Novartis, Eli Lilly, Oramed Pharmaceuticals, Dongbao Enterprise Group Co., Ltd., and Biocon.Product Type Segment AnalysisIntermediate Acting InsulinShort Acting InsulinRapid Acting InsulinLong Acting InsulinSource Segment AnalysisHuman Recombinant InsulinInsulin AnalogsAdministration Segment AnalysisPumpsInjectionsApplication Segment AnalysisInsulin for Type I DiabetesInsulin for Type II DiabetesRegional Segment Analysis North AmericaEuropeAsia PacificLatin AmericaMiddle East and AfricaFor more information about this report visit https://www.researchandmarkets.com/r/7eq75vResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceMost romantic destinations in North America ranked: The Points GuyYahoo Finance VideoUnited pulls Boeing's 737 Max jets through June 2020Yahoo Finance VideoBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo FinanceWhat to watch in the markets: Friday, February 28Yahoo Finance VideoSomething 'dangerous' is happening beneath the surface of the market selloffYahoo Finance